Home › Companies › AbbVie Inc. › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and AbbVie Inc.’s Form 8-K, filed May 12, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 8, 2026: 8 items on AbbVie Inc.’s Form 8-K, filed May 12, 2026: 2 approved · 4 passed (calculated) · 2 not approved.
Significant dissent: 1 shareholder proposal (39.6% support).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore AbbVie Inc. in the interactive database Compare manager voting policies
These tallies are AbbVie Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 12, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Jennifer L. Davis | 1,216,558,754 | 89,839,329 | 2,680,369 | -- | 239,399,581 | 93% | Passed (calculated) | — |
| Elect Director: Melody B. Meyer | 1,284,771,578 | 22,470,074 | 1,836,800 | -- | 239,399,581 | 98% | Passed (calculated) | — |
| Elect Director: Robert A. Michael | 1,221,224,370 | 85,865,852 | 1,988,230 | -- | 239,399,581 | 93% | Passed (calculated) | — |
| Elect Director: Frederick H. Waddell | 1,225,237,825 | 81,747,033 | 2,093,594 | -- | 239,399,581 | 94% | Passed (calculated) | — |
| 2. The appointment of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2026 | 1,522,575,012 | 23,766,564 | 2,136,457 | -- | -- | 98% | Approved | — |
| 3. The compensation of AbbVie's named executive officers | 1,228,615,745 | 69,336,359 | 11,126,348 | -- | 239,399,581 | 95% | Approved | — |
| 4. Management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting | 1,290,990,023 | 14,896,119 | 3,192,310 | -- | 239,399,581 | 99% | Not approved Not approved: the filing states that this item needed more than a majority of the votes cast. | — |
| 5. Stockholder proposal to adopt a policy to require an independent chair | 515,626,009 | 787,253,970 | 6,198,473 | -- | 239,399,581 | 40% | Not approved | — |
Source: AbbVie Inc., Form 8-K, filed with the SEC on May 12, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
1,747 asset managers disclosed a vote on at least one AbbVie Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 9 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors: Jennifer L. Davis
AbbVie Inc.’s own tally for this item (“Elect Director: Jennifer L. Davis”): 1,216,558,754 for, 89,839,329 against, per its Form 8-K filed May 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 277 asset managers below reported 495,797,861 for, 10,622,150 against, 84,467 abstained, 1,342 not voted, 81,392 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 168,617,828 | 1,083 | 44 | 0 | For |
| Fidelity | 57,643,205 | 573,691 | 0 | 0 | For |
| BlackRock | 55,981,904 | 0 | 0 | 0 | For |
| Capital Group | 48,531,383 | 0 | 0 | 0 | For |
| Charles Schwab | 24,144,556 | 0 | 0 | 0 | For |
| State Street | 21,332,913 | 0 | 0 | 0 | For |
| JPMorgan | 19,167,904 | 0 | 0 | 0 | For |
| TIAA | 9,206,666 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 8,308,752 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,541 | 6,782,949 | 0 | 0 | Against |
| Columbia Threadneedle | 6,281,589 | 0 | 0 | 0 | For |
| Invesco | 5,225,217 | 0 | 0 | 0 | For |
| Putnam | 4,765,880 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,246,906 | 0 | 0 | 0 | For |
| MFS | 3,857,564 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 3,412,189 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,728,208 | 0 | 0 | 0 | For |
| Dimensional | 2,654,706 | 0 | 0 | 0 | For |
| Federated Hermes | 2,542,959 | 0 | 0 | 0 | For |
| WisdomTree | 2,265,443 | 0 | 0 | 0 | For |
| Prudential/PGIM | 2,161,417 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 2,105,000 | 0 | 0 | 0 | For |
| John Hancock | 1,141,016 | 933,978 | 0 | 0 | Mixed |
| Jackson National | 2,001,360 | 2,108 | 0 | 0 | For |
| American Century | 1,941,783 | 0 | 0 | 0 | For |
Showing the 25 largest of 277 asset managers. All 277 are in the interactive database (link above).
Combines 8 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors: Melody B. Meyer
AbbVie Inc.’s own tally for this item (“Elect Director: Melody B. Meyer”): 1,284,771,578 for, 22,470,074 against, per its Form 8-K filed May 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 277 asset managers below reported 497,832,471 for, 8,587,555 against, 84,452 abstained, 1,342 not voted, 81,392 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 168,618,576 | 350 | 29 | 0 | For |
| Fidelity | 57,643,205 | 573,691 | 0 | 0 | For |
| BlackRock | 55,981,904 | 0 | 0 | 0 | For |
| Capital Group | 48,531,383 | 0 | 0 | 0 | For |
| Charles Schwab | 24,144,556 | 0 | 0 | 0 | For |
| State Street | 21,332,913 | 0 | 0 | 0 | For |
| JPMorgan | 19,167,904 | 0 | 0 | 0 | For |
| TIAA | 9,206,666 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 8,308,752 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,541 | 6,782,949 | 0 | 0 | Against |
| Columbia Threadneedle | 6,281,589 | 0 | 0 | 0 | For |
| Invesco | 5,225,217 | 0 | 0 | 0 | For |
| Putnam | 4,765,880 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,246,906 | 0 | 0 | 0 | For |
| MFS | 3,857,564 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 3,412,189 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,728,208 | 0 | 0 | 0 | For |
| Dimensional | 2,654,706 | 0 | 0 | 0 | For |
| Federated Hermes | 2,542,959 | 0 | 0 | 0 | For |
| WisdomTree | 2,265,443 | 0 | 0 | 0 | For |
| Prudential/PGIM | 2,161,417 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 2,105,000 | 0 | 0 | 0 | For |
| John Hancock | 1,141,016 | 933,978 | 0 | 0 | Mixed |
| Jackson National | 2,001,360 | 2,108 | 0 | 0 | For |
| American Century | 1,941,783 | 0 | 0 | 0 | For |
Showing the 25 largest of 277 asset managers. All 277 are in the interactive database (link above).
Combines 9 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors: Robert A. Michael
AbbVie Inc.’s own tally for this item (“Elect Director: Robert A. Michael”): 1,221,224,370 for, 85,865,852 against, per its Form 8-K filed May 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 277 asset managers below reported 504,728,050 for, 1,691,975 against, 84,455 abstained, 1,342 not voted, 81,392 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 168,617,646 | 1,279 | 32 | 0 | For |
| Fidelity | 58,216,896 | 0 | 0 | 0 | For |
| BlackRock | 55,981,904 | 0 | 0 | 0 | For |
| Capital Group | 48,531,383 | 0 | 0 | 0 | For |
| Charles Schwab | 24,144,556 | 0 | 0 | 0 | For |
| State Street | 21,332,723 | 190 | 0 | 0 | For |
| JPMorgan | 19,167,904 | 0 | 0 | 0 | For |
| TIAA | 9,206,666 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 8,308,752 | 0 | 0 | 0 | For |
| T. Rowe Price | 6,788,490 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 6,281,589 | 0 | 0 | 0 | For |
| Invesco | 5,225,217 | 0 | 0 | 0 | For |
| Putnam | 4,765,880 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,246,906 | 0 | 0 | 0 | For |
| MFS | 3,857,564 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 3,412,189 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,728,208 | 0 | 0 | 0 | For |
| Dimensional | 2,654,706 | 0 | 0 | 0 | For |
| Federated Hermes | 2,542,959 | 0 | 0 | 0 | For |
| WisdomTree | 2,265,443 | 0 | 0 | 0 | For |
| Prudential/PGIM | 2,161,417 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 2,105,000 | 0 | 0 | 0 | For |
| John Hancock | 1,172,344 | 902,650 | 0 | 0 | Mixed |
| Jackson National | 2,003,468 | 0 | 0 | 0 | For |
| American Century | 1,941,783 | 0 | 0 | 0 | For |
Showing the 25 largest of 277 asset managers. All 277 are in the interactive database (link above).
Combines 9 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors: Frederick H. Waddell
AbbVie Inc.’s own tally for this item (“Elect Director: Frederick H. Waddell”): 1,225,237,825 for, 81,747,033 against, per its Form 8-K filed May 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 277 asset managers below reported 496,910,236 for, 9,509,784 against, 84,456 abstained, 1,342 not voted, 81,392 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 168,617,678 | 1,241 | 33 | 0 | For |
| Fidelity | 57,643,205 | 573,691 | 0 | 0 | For |
| BlackRock | 55,981,904 | 0 | 0 | 0 | For |
| Capital Group | 48,531,383 | 0 | 0 | 0 | For |
| Charles Schwab | 24,144,556 | 0 | 0 | 0 | For |
| State Street | 21,332,566 | 347 | 0 | 0 | For |
| JPMorgan | 19,167,904 | 0 | 0 | 0 | For |
| TIAA | 9,206,666 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 8,308,752 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,541 | 6,782,949 | 0 | 0 | Against |
| Columbia Threadneedle | 6,281,589 | 0 | 0 | 0 | For |
| Invesco | 5,225,217 | 0 | 0 | 0 | For |
| Putnam | 4,765,880 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,246,906 | 0 | 0 | 0 | For |
| MFS | 3,857,564 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 3,412,189 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,728,208 | 0 | 0 | 0 | For |
| Dimensional | 2,654,706 | 0 | 0 | 0 | For |
| Federated Hermes | 2,542,959 | 0 | 0 | 0 | For |
| WisdomTree | 2,265,443 | 0 | 0 | 0 | For |
| Prudential/PGIM | 2,161,417 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 2,105,000 | 0 | 0 | 0 | For |
| John Hancock | 1,141,016 | 933,978 | 0 | 0 | Mixed |
| Jackson National | 2,001,360 | 2,108 | 0 | 0 | For |
| American Century | 1,941,783 | 0 | 0 | 0 | For |
Showing the 25 largest of 277 asset managers. All 277 are in the interactive database (link above).
Combines 9 wordings of this item as funds reported it.
99% Not approved · of votes cast
Description as filed by funds: Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting
AbbVie Inc.’s own tally for this item (“4. The management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting”): 1,290,990,023 for, 14,896,119 against — failed, per its Form 8-K filed May 12, 2026 (Item 5.07). This item required more than a simple majority of votes cast — see the filing.
Reported outcome: Not approved, in the filing’s own words: “(4) The stockholders did not approve the management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting, as follows:”
Not approved: the filing states that this item needed more than a majority of the votes cast.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of AbbVie Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Eliminate Supermajority Vote Requirement” (9 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).
The 279 asset managers below reported 506,152,138 for, 25,238 against, 47 abstained, 1,342 not voted, 10,390 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 168,618,669 | 238 | 47 | 0 | For |
| Fidelity | 58,216,896 | 0 | 0 | 0 | For |
| BlackRock | 55,981,904 | 0 | 0 | 0 | For |
| Capital Group | 48,531,383 | 0 | 0 | 0 | For |
| Charles Schwab | 24,144,556 | 0 | 0 | 0 | For |
| State Street | 21,332,913 | 0 | 0 | 0 | For |
| JPMorgan | 19,167,904 | 0 | 0 | 0 | For |
| TIAA | 9,206,666 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 8,308,752 | 0 | 0 | 0 | For |
| T. Rowe Price | 6,788,490 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 6,281,589 | 0 | 0 | 0 | For |
| Invesco | 5,225,217 | 0 | 0 | 0 | For |
| Putnam | 4,765,880 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,246,906 | 0 | 0 | 0 | For |
| MFS | 3,857,564 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 3,412,189 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,728,208 | 0 | 0 | 0 | For |
| Dimensional | 2,654,706 | 0 | 0 | 0 | For |
| Federated Hermes | 2,542,959 | 0 | 0 | 0 | For |
| WisdomTree | 2,265,443 | 0 | 0 | 0 | For |
| Prudential/PGIM | 2,161,417 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 2,105,000 | 0 | 0 | 0 | For |
| John Hancock | 2,074,994 | 0 | 0 | 0 | For |
| Jackson National | 2,003,468 | 0 | 0 | 0 | For |
| American Century | 1,941,783 | 0 | 0 | 0 | For |
Showing the 25 largest of 279 asset managers. All 279 are in the interactive database (link above).
Combines 10 wordings of this item as funds reported it.
95% Approved · of votes cast
Prior year: 93.8% for (May 9, 2025 meeting) ▲ 0.8 pts
Description as filed by funds: Say on Pay - An advisory vote on the approval of executive compensation
AbbVie Inc.’s own tally for this item (“3. The compensation of AbbVie's named executive officers”): 1,228,615,745 for, 69,336,359 against — passed, per its Form 8-K filed May 12, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(3) The stockholders approved, on an advisory basis, the compensation of AbbVie's named executive officers, as follows:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of AbbVie Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (137 managers, Fund and manager reports combined; may count the same shares twice; no share total shown); “SAY ON PAY” (7 managers, 557,594 for); “Say on Pay - An advisory vote on the approval of executive H” (3 managers, 18,297 for); “Say on Pay - An advisory vote on the approval of executive compensation More Details” (3 managers, 29,600 for).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 168,617,861 | 914 | 181 | 0 | For |
| Fidelity | 58,216,896 | 0 | 0 | 0 | For |
| BlackRock | 55,981,904 | 0 | 0 | 0 | For |
| Capital Group | 48,531,383 | 0 | 0 | 0 | For |
| Charles Schwab | 24,144,556 | 0 | 0 | 0 | For |
| State Street | 21,332,566 | 347 | 0 | 0 | For |
| JPMorgan | 19,167,904 | 0 | 0 | 0 | For |
| TIAA | 9,206,666 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 8,308,752 | 0 | 0 | 0 | For |
| T. Rowe Price | 6,788,490 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 6,281,589 | 0 | 0 | 0 | For |
| Invesco | 5,225,217 | 0 | 0 | 0 | For |
| Putnam | 4,765,880 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,246,906 | 0 | 0 | 0 | For |
| MFS | 3,857,564 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 3,412,189 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,728,208 | 0 | 0 | 0 | For |
| Dimensional | 2,654,706 | 0 | 0 | 0 | For |
| Federated Hermes | 2,542,959 | 0 | 0 | 0 | For |
| WisdomTree | 2,265,443 | 0 | 0 | 0 | For |
| Prudential/PGIM | 2,161,417 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 2,105,000 | 0 | 0 | 0 | For |
| John Hancock | 2,074,994 | 0 | 0 | 0 | For |
| Jackson National | 2,003,468 | 0 | 0 | 0 | For |
| American Century | 1,941,783 | 0 | 0 | 0 | For |
Fund voting reports, all 251 managers: 503,238,304 for, 1,808,559 against, 1,201,192 abstained, 1,343 not voted, 10,390 unknown. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 72,418,866 | 8,236 | 0 | 0 | For |
| State Street | 51,402,876 | 529,440 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 46,449,184 | 0 | 0 | 0 | For |
| Capital Research Global Investors | 30,971,715 | 0 | 0 | 0 | For |
| Capital Group | 27,875,083 | 0 | 3,824 | 0 | For |
| Charles Schwab | 26,006,547 | 0 | 0 | 0 | For |
| Fidelity | 19,459,094 | 0 | 0 | 0 | For |
| Vanguard | 18,753,074 | 0 | 0 | 0 | For |
| Northern Trust | 18,082,428 | 156,789 | 0 | 0 | For |
| T. Rowe Price | 15,470,981 | 50,230 | 0 | 0 | For |
| UBS | 13,135,171 | 979,746 | 0 | 0 | Mixed |
| Janus Henderson | 12,778,160 | 19,172 | 0 | 0 | For |
| Amundi | 11,778,644 | 104,967 | 0 | 0 | For |
| Nuveen | 10,301,425 | 329 | 0 | 0 | For |
| Invesco | 9,727,592 | 13 | 2 | 0 | For |
| MELLON INVESTMENTS Corp | 8,712,579 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 8,631,742 | 0 | 0 | 0 | For |
| Fisher Asset Management, LLC | 8,246,054 | 0 | 0 | 0 | For |
| Goldman Sachs | 7,981,807 | 0 | 0 | 0 | For |
| Wellington | 7,970,266 | 0 | 0 | 0 | For |
| Legal & General Investment Management Ltd | 184,268 | 7,579,293 | 0 | 0 | Against |
| Putnam | 7,001,318 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 6,843,162 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 6,695,276 | 0 | 0 | 0 | For |
| National Pension Service | 5,274,563 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1,401 managers: 699,577,133 for, 33,969,873 against, 1,462 withheld, 4,455,623 abstained, 379,564 not voted, 71,002 unknown, 8,923 mixed. Showing the 25 largest; every one is in the interactive database (link above).
Combines 11 wordings of this item as funds reported it.
98% Approved · of votes cast
Prior year: 98.2% for (May 9, 2025 meeting) ▲ 0.2 pts
Description as filed by funds: Ratification of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2026
AbbVie Inc.’s own tally for this item (“2. The appointment of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2026”): 1,522,575,012 for, 23,766,564 against — passed, per its Form 8-K filed May 12, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “(2) The stockholders ratified the appointment of Ernst & Young LLP as AbbVie's independent registered public accounting firm for 2026, as follows:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 283 asset managers below reported 506,751,094 for, 18,993 against, 84,446 abstained, 1,342 not voted, 81,392 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 168,618,587 | 344 | 23 | 0 | For |
| Fidelity | 58,216,896 | 0 | 0 | 0 | For |
| BlackRock | 55,981,904 | 0 | 0 | 0 | For |
| Capital Group | 48,531,383 | 0 | 0 | 0 | For |
| Charles Schwab | 24,144,556 | 0 | 0 | 0 | For |
| State Street | 21,332,566 | 347 | 0 | 0 | For |
| JPMorgan | 19,167,904 | 0 | 0 | 0 | For |
| TIAA | 9,206,666 | 0 | 0 | 0 | For |
| INVESTMENT CO OF AMERICA | 8,308,752 | 0 | 0 | 0 | For |
| T. Rowe Price | 6,788,490 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 6,281,589 | 0 | 0 | 0 | For |
| Invesco | 5,225,217 | 0 | 0 | 0 | For |
| Putnam | 4,765,880 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,246,906 | 0 | 0 | 0 | For |
| MFS | 3,857,564 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 3,412,189 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,728,208 | 0 | 0 | 0 | For |
| Dimensional | 2,654,706 | 0 | 0 | 0 | For |
| Federated Hermes | 2,542,959 | 0 | 0 | 0 | For |
| WisdomTree | 2,265,443 | 0 | 0 | 0 | For |
| Prudential/PGIM | 2,161,417 | 0 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 2,105,000 | 0 | 0 | 0 | For |
| John Hancock | 2,074,994 | 0 | 0 | 0 | For |
| Jackson National | 2,003,468 | 0 | 0 | 0 | For |
| American Century | 1,941,783 | 0 | 0 | 0 | For |
Showing the 25 largest of 283 asset managers. All 283 are in the interactive database (link above).
Proposed by: Mercy Investment Services, Inc. and co-filers
Combines 5 wordings of this item as funds reported it.
40% Not approved · of votes cast
Description as filed by funds: Stockholder Proposal - to Adopt a Policy to Require an Independent Chair
AbbVie Inc.’s own tally for this item (“5. A stockholder proposal to adopt a policy to require an independent chair”): 515,626,009 for, 787,253,970 against — failed, per its Form 8-K filed May 12, 2026 (Item 5.07).
Reported outcome: Not approved, in the filing’s own words: “(5) The stockholders did not approve a stockholder proposal to adopt a policy to require an independent chair, as follows:”
Support: 40% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 279 asset managers below reported 113,211,991 for, 393,280,948 against, 84,518 abstained, 1,342 not voted, 12,442 unknown.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,633,619 | 163,985,239 | 95 | 0 | Against |
| Fidelity | 241,451 | 57,975,445 | 0 | 0 | Against |
| BlackRock | 63,430 | 55,918,474 | 0 | 0 | Against |
| Capital Group | 48,531,383 | 0 | 0 | 0 | For |
| Charles Schwab | 3,014 | 24,141,542 | 0 | 0 | Against |
| State Street | 10,182 | 21,322,731 | 0 | 0 | Against |
| JPMorgan | 0 | 19,167,904 | 0 | 0 | Against |
| TIAA | 0 | 9,206,666 | 0 | 0 | Against |
| INVESTMENT CO OF AMERICA | 8,308,752 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 6,788,490 | 0 | 0 | Against |
| Columbia Threadneedle | 6,281,589 | 0 | 0 | 0 | For |
| Invesco | 3,287,483 | 1,937,734 | 0 | 0 | Mixed |
| Putnam | 4,765,880 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 4,246,906 | 0 | 0 | 0 | For |
| MFS | 0 | 3,857,564 | 0 | 0 | Against |
| Franklin Custodian Funds | 3,412,189 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 0 | 2,728,208 | 0 | 0 | Against |
| Dimensional | 0 | 2,654,706 | 0 | 0 | Against |
| Federated Hermes | 2,542,959 | 0 | 0 | 0 | For |
| WisdomTree | 0 | 2,265,443 | 0 | 0 | Against |
| Prudential/PGIM | 2,129,364 | 32,053 | 0 | 0 | For |
| FRANKLIN MANAGED TRUST | 2,105,000 | 0 | 0 | 0 | For |
| John Hancock | 2,022,903 | 52,091 | 0 | 0 | For |
| Jackson National | 102,211 | 1,901,257 | 0 | 0 | Mixed |
| American Century | 0 | 1,941,783 | 0 | 0 | Against |
Showing the 25 largest of 279 asset managers. All 279 are in the interactive database (link above).
Not shown here: this season’s fund filings also report 2 items from the meeting of May 9, 2025, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 1,766,792,821 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 9.54% |
| 2 | Fidelity | 3.30% |
| 3 | BlackRock | 3.17% |
| 4 | Capital Group | 2.75% |
| 5 | Charles Schwab | 1.37% |
| 6 | State Street | 1.21% |
| 7 | JPMorgan | 1.08% |
| 8 | TIAA | 0.52% |
| 9 | INVESTMENT CO OF AMERICA | 0.47% |
| 10 | T. Rowe Price | 0.38% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 4.10% |
| 2 | State Street | 2.94% |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 2.63% |
| 4 | Capital Research Global Investors | 1.75% |
| 5 | Capital Group | 1.58% |
| 6 | Charles Schwab | 1.47% |
| 7 | Fidelity | 1.10% |
| 8 | Vanguard | 1.06% |
| 9 | Northern Trust | 1.03% |
| 10 | T. Rowe Price | 0.88% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Vanguard Group | 180,779,699 | 10.23% | Form 13F, quarter ended March 31, 2026 |
| BlackRock | 150,749,625 | 8.53% | Form 13F, quarter ended March 31, 2026 |
| State Street | 81,217,516 | 4.60% | Form 13F, quarter ended March 31, 2026 |
| JPMorgan Chase | 56,741,691 | 3.21% | Form 13F, quarter ended March 31, 2026 |
| Morgan Stanley | 40,041,940 | 2.27% | Form 13F, quarter ended March 31, 2026 |
| FMR (Fidelity) | 21,762,703 | 1.23% | Form 13F, quarter ended March 31, 2026 |
| Northern Trust | 21,211,382 | 1.20% | Form 13F, quarter ended March 31, 2026 |
| Goldman Sachs | 16,437,679 | 0.93% | Form 13F, quarter ended March 31, 2026 |
| Franklin Templeton | 14,552,069 | 0.82% | Form 13F, quarter ended March 31, 2026 |
Percentages above are of 1,766,792,821 shares outstanding, as reported by AbbVie Inc. on its Form 10-Q dated April 28, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At AbbVie Inc.'s shareholder meeting held May 8, 2026, in the 2025-2026 proxy season, 1,747 asset managers reported votes on at least one of its 8 ballot items in their SEC Form N-PX filings, covering 15,837 separate fund positions. On the most widely held item on that ballot — Say on Pay - An advisory vote on the approval of executive compensation — AbbVie Inc.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: AbbVie Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 12, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AbbVie Inc.’s 10-Q dated April 28, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
AbbVie Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “AbbVie (ABBV) 2026 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/abbvie-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.